Trans-catheter arterial p53-gene-embolization using gelatin sponge particles in treatment of patients with advanced hepatocellular carcinoma.
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2013
Price : $35 *
At a glance
- Drugs Contusugene ladenovec (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 24 Jun 2013 New trial record
- 31 May 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.